DALLAS, April 5, 2006 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site is initiating Profile Coverage for Neuroscience Therapy Corporation (Pink Sheets:NPYC). The P-Stim Electro Stimulation device and the Multi-Point stylus. It is capable of relieving pain almost anywhere in the body and has the potential to treat many other clinical conditions. This device has been used on several thousand patients in Europe.
The advantage of using the ear for such treatment is that it offers a concentration of free nerve ends and numerous acupuncture points for stimulation within a small area. Stimulation is performed by electrical pulses emitted through tiny, precisely positioned needles.
To view the StockGuru.com Profile for Neuroscience Therapy Corporation, please visit:
http://www.stockguru.com/profiles/npyc/
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit:
http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.
Legal Notice Regarding Forward Looking Statements
The statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain ``forward-looking statements'' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
Disclosure: Pentony Enterprises LLC was compensated fifty thousand free trading shares for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.